Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 196
- A Letter From the Tacoma City Council to the Sound Transit Board
- Tacoma City Council Member Kristina Walker to Share Sound Transit Updates During March 31 Study Session
BELLEVUE, Wash. - Washingtoner -- mpathic, a leading provider of AI-powered emotional intelligence solutions, is proud to announce that it has successfully completed SOC 2 Type II audit. This audit further solidifies the company's dedication to data security and compliance.
SOC 2 Type II compliance is a rigorous and internationally recognized standard that validates a company's commitment to safeguarding sensitive information and ensuring the highest level of data security and privacy for its clients.
By undergoing a thorough and independent audit from a leading audit body, mpathic has demonstrated its robust internal controls and processes for data protection, availability, and confidentiality. This certification provides valuable assurance to mpathic's clients that their data is handled with the utmost care and security.
Key highlights of mpathic's completion of the SOC 2 Type II audit include:
More on Washingtoner
Brian Williams, Chief Technology & Information Security Officer of mpathic, commented on this significant achievement, saying, "We understand the critical importance of data security and compliance in our industry. The completion of the SOC 2 Type II audit underscores our unwavering commitment to maintaining the highest standards of data protection and security for our clients. We believe that our clients' trust is the foundation of our success, and this compliance is a testament to that trust."
mpathic's successful completion of the SOC 2 Type II audit exemplifies the company's ongoing efforts to deliver cutting-edge solutions while prioritizing data security, privacy, and regulatory compliance.
For more information about mpathic and its SOC 2 Type II audit, please visit mpathic.ai.
Follow our blog (https://www.mpathic.ai/blog) and connect with us on LinkedIn (https://www.linkedin.com/company/mpathic-ai/).
More on Washingtoner
About mpathic
mpathic (https://www.mpathic.ai/) is a trusted leader in actionable conversation analytics, empowering healthcare, pharma, sales, and service leaders to deliver exceptional care and engagement. With our proprietary ML models, developed through over 10 years of scientific validation, mpathic achieves up to 7 times the accuracy of human doctors. Our platform objectively detects, corrects, and enhances over 90 behaviors, establishing an unrivaled level of trust.
SOC 2 Type II compliance is a rigorous and internationally recognized standard that validates a company's commitment to safeguarding sensitive information and ensuring the highest level of data security and privacy for its clients.
By undergoing a thorough and independent audit from a leading audit body, mpathic has demonstrated its robust internal controls and processes for data protection, availability, and confidentiality. This certification provides valuable assurance to mpathic's clients that their data is handled with the utmost care and security.
Key highlights of mpathic's completion of the SOC 2 Type II audit include:
- Stringent Security Measures: mpathic has implemented stringent security measures to protect client data from unauthorized access, ensuring data integrity and confidentiality throughout its systems.
- Continuous Monitoring: mpathic's commitment to data security extends to continuous monitoring and auditing of its internal controls, guaranteeing the effectiveness of security measures over time.
- Comprehensive Compliance: mpathic adheres to the highest industry standards, including HIPAA and GDPR, to ensure compliance with data protection regulations specific to healthcare and clinical research.
More on Washingtoner
- Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
- Dental Implants in Everett, WA: 19th Avenue Dental Offers Permanent Tooth Replacement Solutions
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
- NAIDOC Week Australia 2026 | 50 Years Deadly - Celebrates Culture, Resilience, and Global Connection
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
Brian Williams, Chief Technology & Information Security Officer of mpathic, commented on this significant achievement, saying, "We understand the critical importance of data security and compliance in our industry. The completion of the SOC 2 Type II audit underscores our unwavering commitment to maintaining the highest standards of data protection and security for our clients. We believe that our clients' trust is the foundation of our success, and this compliance is a testament to that trust."
mpathic's successful completion of the SOC 2 Type II audit exemplifies the company's ongoing efforts to deliver cutting-edge solutions while prioritizing data security, privacy, and regulatory compliance.
For more information about mpathic and its SOC 2 Type II audit, please visit mpathic.ai.
Follow our blog (https://www.mpathic.ai/blog) and connect with us on LinkedIn (https://www.linkedin.com/company/mpathic-ai/).
More on Washingtoner
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
About mpathic
mpathic (https://www.mpathic.ai/) is a trusted leader in actionable conversation analytics, empowering healthcare, pharma, sales, and service leaders to deliver exceptional care and engagement. With our proprietary ML models, developed through over 10 years of scientific validation, mpathic achieves up to 7 times the accuracy of human doctors. Our platform objectively detects, corrects, and enhances over 90 behaviors, establishing an unrivaled level of trust.
Source: mpathic
0 Comments
Latest on Washingtoner
- Century Fasteners Corp. Exhibiting at 2026 MRO Americas Show – April 21-23, 2026 – Booth #2257
- Blue Sparrow Coffee named Best Matcha in Westword's Best of Denver 2026
- Ocean County College Introduces Pathways to Simplify the Student Journey and Strengthen Career Connections
- Kiko Nation Expands to Apple App Store, Achieving Full Mobile Deployment for Livestock Digital Registry Platform
- The Lawyers' Marketer Launches Claude AI Implementation Service for Law Firms
- Certified Trading Card Association and Collectors MD Launch Healthy Hobby Initiative
- A Letter From the Tacoma City Council to the Sound Transit Board
- Tacoma: City Council Approves Contract, Officially Appointing Hyun Kim as City Manager
- Tacoma: Homicide Investigation – 3400 Block South 19th Street
- L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
- Women-Owned Business Platform SmartPath Launches to Help Entrepreneurs Build with Confidence
- FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
- HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
- City of Spokane Celebrates Return of Spokane Gives
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)